Eldepryl 5 mg Tablets *
Company:
Orion Pharma (Ireland) LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 18 February 2021
File name
Eldepryl 5mg tabl PIL 120121_1613649914.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Free text change information supplied by the pharmaceutical company
The following information has been added to the leaflet (warnings and precautions):
The use of Eldepryl together with buprenorphine can lead to serotonin syndrome, a potentially life-threatening condition.
Updated on 18 February 2021
File name
Eldepryl 5mg tabl SPC 150221_1613649789.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.4: Information on concomitant buprenorphine added:
Concomitant administration of selegiline and buprenorphine may result in serotonin syndrome, a potentially life-threatening condition. If concomitant treatment with buprenorphine is clinically warranted, careful observation of the
patient is advised, particularly during treatment initiation and dose increases. Symptoms of serotonin syndrome may include mental-status changes, autonomic instability, neuromuscular abnormalities, and/or gastrointestinal symptoms.
Section 4.5: Information on stopping Eldepry and starting a contra-indicated medication:
At least two weeks should elapse after stopping administration of Eldepryl before starting therapy with any contra-indicated medicinal product.
Updated on 26 November 2019
File name
Eldepryl 5mg tabl PIL 240315_1574765644.pdf
Reasons for updating
- New PIL for new product
Updated on 26 November 2019
File name
Eldepryl 5mg tabl SPC 240315_1574765598.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)